Synergistic effect between 2-N,6-O-sulfonated chitosan and bone morphogenetic protein-2.

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Protein Engineering

Background:

• Sulfonated chitosan exhibits heparin-like properties and potential synergistic effects with bone morphogenetic protein-2 (BMP-2).
• Heparin's clinical application is limited, necessitating exploration of alternatives like sulfonated chitosan for BMP-2 synergy.
• Bone marrow mesenchymal stem cells (BMSCs) are crucial for osteogenesis and can be influenced by biomaterials and growth factors.

Purpose of the Study:

• To investigate the synergistic effect between 2-N,6-O-sulfonated chitosan (26SCS) and BMP-2.
• To evaluate the impact of 26SCS on BMSC proliferation, adhesion, and osteogenic differentiation.
• To elucidate the mechanism underlying the 26SCS-BMP-2 interaction.

Main Methods:

• Preparation and characterization of 26SCS.
• Co-culture of BMSCs with 26SCS.
• Assessment of BMSC proliferation, adhesion, and osteogenic differentiation.
• Circular dichroism and isothermal calorimetric titration to study protein-ligand interactions.

Main Results:

• 26SCS significantly altered the secondary structure of BMP-2, specifically affecting antiparallel β-fold conformation.
• This structural modification enhanced BMP-2's biological activity in a dose-dependent manner.
• 26SCS promoted BMSC proliferation, adhesion, and osteogenic differentiation.

Conclusions:

• 26SCS acts as a synergistic factor for BMP-2, improving its efficacy.
• 26SCS demonstrates potential as a biomaterial for enhancing bone regeneration therapies.
• The findings suggest 26SCS could overcome limitations associated with heparin in clinical BMP-2 applications.